Lv41
480 积分 2022-02-17 加入
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series
6小时前
待确认
Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management
17天前
已关闭
肾脏意义的单克隆免疫球蛋白病发病机制研究进展
17天前
已完结
具有肾脏意义的单克隆免疫球蛋白病的诊断和治疗
17天前
已完结
Monoclonal Gammopathy of Renal Significance
17天前
已完结
Considerations for next therapy after anti-CD38 monoclonal antibodies used as first line
29天前
已关闭
Considerations for next therapy after anti-CD38 monoclonal antibodies used as first line
29天前
已关闭
Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma
1个月前
已完结
Therapeutic progress in relapsed/refractory multiple myeloma
1个月前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
2个月前
已完结
皖公网安备34019202002308
